The price of Haemonetics Corp (NYSE:HAE) shares last traded on Wall Street fell -0.72% to $87.89.
HAE stock price is now 10.59% away from the 50-day moving average and 6.89% away from the 200-day moving average. The market capitalization of the company currently stands at $4.41B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $120, Raymond James recently Upgraded its rating from Outperform to Strong Buy for Haemonetics Corp (NYSE: HAE). On September 13, 2024, CL King recently initiated its ‘Buy’ rating on the stock quoting a target price of $116, while ‘BofA Securities’ rates the stock as ‘Neutral’
In other news, Lingamneni Anila, Former Officer bought 6,238 shares of the company’s stock on Nov 11 ’24. The stock was bought for $565,692 at an average price of $90.68. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 26 ’24, President, Global Hospital Strong Stewart W sold 4,312 shares of the business’s stock. A total of $393,039 was realized by selling the stock at an average price of $91.15. This leaves the insider owning 18,196 shares of the company worth $1.6 million. A total of 1.09% of the company’s stock is owned by insiders.
During the past 12 months, Haemonetics Corp has had a low of $70.25 and a high of $97.97. As of last week, the company has a debt-to-equity ratio of 1.39, a current ratio of 3.49, and a quick ratio of 2.09. According to the stock market information, the enterprise value for the company is $5429118464, which is based on a 36.50 price-to-earnings ratio, a 2.27 price-to-earnings-growth ratio, and a beta of 0.38. The fifty day moving average price for HAE is $79.231 and a two-hundred day moving average price translates $82.1468 for the stock.
The latest earnings results from Haemonetics Corp (NYSE: HAE) was released for 2024-09-28. The net profit margin was 9.10% and return on equity was 13.97% for HAE. The company reported revenue of $345.51 million for the quarter, compared to $318.18 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 8.59 percent.
